Summary
- Profile Type
- Technology offer
- POD Reference
- TOCY20241018015
- Term of Validity
- 18 October 2024 - 18 October 2025
- Company's Country
- Cyprus
- Type of partnership
- Research and development cooperation agreement
- Commercial agreement with technical assistance
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- An innovative healthtech startup focuses on diagnostic imaging and clinical decision-making in healthcare. They combine state-of-the-art Simulation-Based Imaging with AI-driven technologies to enable real-time assessments. Their flagship solutions involve intracranial Aneurysm Rupture Risk Prediction powered by Explainable AI and 4D-Flow MRI imaging. They are seeking research collaboration to validate their imaging technologies through clinical collaborations and co-develop solutions.
- Full Description
-
An Innovative Healthtech startup dedicated to revolutionizing cerebrovascular and cardiovascular diagnostics through cutting-edge technologies, specifically Simulation-Based Imaging (SBI) and Explainable Artificial Intelligence (xAI). Our project focuses on enhancing the prediction of intracranial aneurysm rupture risk and providing real-time 4D Flow MRI imaging for cardiovascular diseases.
Innovative Approach
SBI integrates advanced computational modeling with medical imaging, enabling clinicians to make more informed decisions based on accurate and actionable insights. By combining high-resolution imaging with xAI, we enhance the transparency and interpretability of AI-driven diagnostics, addressing the critical need for reliable tools in cerebrovascular and cardiovascular imaging.
Key Objectives
1. Intracranial Aneurysm Rupture Risk Prediction: Using xAI, we analyze blood flow patterns and vessel wall stress to provide clinicians with actionable information that enhances preventive treatment strategies for patients at risk of aneurysm rupture.
2. Enhanced Imaging Capabilities: Our technology significantly improves spatial resolution by up to 6 times greater than conventional methods, while reducing scan times by up to 80%. This allows for faster patient work-up and more detailed image visualization of cardiovascular and cerebrovascular structures.
3. Versatile Applications: Sim4Flow’s innovative solutions are adaptable across various imaging modalities, including MRI and CT, making them suitable for a range of applications, including heart disease and abdominal aortic aneurysms.
4. Real-Time Diagnostics: By enabling real-time image reconstruction, SBI enhances clinical workflows and allows for immediate, well-informed decision-making, thereby improving patient outcomes.
Collaborations and Partnerships
The startup seeks partnerships with healthcare providers, medtech companies, and research institutions to advance our mission. We are particularly interested in collaborations for AI model training, image analysis, and clinical validation. In addition, we aim to engage in international and regional programs, such as Horizon Europe and Interreg, to foster further development and dissemination of our technology.
Conclusion:
Leveraging the power of SBI and xAI, Sim4Flow is poised to transform the landscape of cerebrovascular and cardiovascular diagnostics. Our innovative approach not only improves clinical outcomes, but also aims to reduce healthcare costs and improve patient’s the quality of life. Join us on this groundbreaking journey to advance precision diagnostics and redefine the future of cardiovascular healthcare - Advantages and Innovations
-
This innovative approach to cardiovascular and cerebrovascular diagnostics through Simulation-Based Imaging (SBI) and Explainable Artificial Intelligence (xAI) represents a significant advancement in medical imaging. We aim to revolutionize intracranial aneurysm rupture risk prediction and cardiovascular MRI diagnòstics. Key innovations include:
Intracranial Aneurysm Rupture Risk Prediction: By simulating blood flow dynamics, SBI provides clinicians with useful insights enabling more accurate aneurysm rupture risk assessment.
xAI: Unlike traditional "black-box" AI models, their xAI offers transparency allowing clinicians to cross-check AI-generated insights with their knowledge increasing trust and interpretability.
Versatility: Our technology extends beyond intracranial aneurysms to conditions like abdominal aortic aneurysms and other vascular pathologies offering a multi-purpose diagnostic platform.
AI-Driven Accuracy with Limited Data: Our advanced AI algorithms can extract precise diagnostic information from limited or incomplete data. We’ve built a robust database of approximately 1200 intracranial aneurysm cases to train our models.
Faster Image Reconstruction: They provide rapid image analysis, enhancing decision-making in high-risk cases like suspected aneurysm rupture helping reduce delays and improve patient outcomes.
Cost-Effective and Scalable: It can be deployed on existing imaging Systems eliminating the need for costly new hardware making it accessible to more healthcare providers.
Ethical AI: With growing concerns around AI ethics and safety, our xAI ensures transparency, traceability, and clinical interpretability, addressing these challenges head-on.
The SME's innovations translate into meaningful improvements in clinical workflows, patient care, and healthcare cost savings. The SME actively seeks collaborations with MedTech companies, research institutions, and healthcare providers for AI model training, image analysis, clinical validation - Stage of Development
- Under development
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
- IPR description
- 1. Distribution. 2. Co-development and distribution. 3. Licensing the device to the partner.
Partner Sought
- Expected Role of a Partner
- 1. Distribution. 2. Co-development and distribution. 3. Licensing the device to the partner.
- Type and Size of Partner
- SME 11-49
- SME 50 - 249
- R&D Institution
- University
- SME <=10
- Type of partnership
- Research and development cooperation agreement
- Commercial agreement with technical assistance
Dissemination
- Technology keywords
- 06001005 - Diagnostics, Diagnosis
- 06001013 - Medical Technology / Biomedical Engineering
- Market keywords
- 05001001 - Diagnostic services
- 05002005 - Other medical imaging
- Sector Groups Involved
- Health
- Digital
- Targeted countries
- All countries